Puma Biotechnology, Inc.

NASDAQ:PBYI

Biotechnology

Healthcare
$7.22 +2.21%

+$0.16 today

Market cap
$373.26M
Beta
1.21
P/E (TTM)
15.4
EPS (TTM)
$0.48
52W Low $3.03High $7.90

Volume 0.45M

Average 0.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$216.30M

FY 2025 · Annual

+1.4% YoY

Liabilities

$85.96M

FY 2025 · Annual

-29.1% YoY

Equity

$130.34M

FY 2025 · Annual

+41.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents63.13M76.2M84.59M69.22M29.64M
Short-term Investments18.98M4.87M11.35M31.75M67.89M
Net Receivables32.53M42.27M48.49M32.01M53.65M
Inventory7.11M4.53M7.08M8.72M5.52M
Other Current Assets11.43M1.95M260K3.7M4M
Total Current Assets140.02M134.28M156.19M147.66M162.69M
Property, Plant & Equipment (Net)15.77M12.51M8.65M5.09M5.56M
Goodwill00000
Intangible Assets66.13M70.61M60.87M51.13M41.39M
Long-term Investments002.09M00
Tax Assets0007.08M3.83M
Other Non-current Assets4.67M4.66M2.73M2.38M2.83M
Total Non-current Assets86.56M87.78M74.34M65.68M53.62M
Total Assets226.59M222.06M230.53M213.33M216.3M
Account Payables11.17M6.44M6.89M5.51M5.06M
Short-term Debt0034M45.33M22.52M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities11.22M13.34M43.42M15.18M16.5M
Total Current Liabilities109.59M77.48M99.38M96.11M81.25M
Long-term Debt97.09M98.31M65.66M21.72M4.71M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities6.38M12.83M5.01M1.88M0
Total Non-current Liabilities119.45M122.97M77.7M25.1M4.71M
Total Liabilities229.03M200.45M177.09M121.21M85.96M
Common Stock4K5K5K5K5K
Retained Earnings(1.37B)(1.37B)(1.35B)(1.31B)(1.28B)
Accumulated OCI(2K)0(4K)6K36K
Other Stockholders Equity0(0)000
Minority Interest00000
Total Equity(2.45M)21.61M53.44M92.13M130.34M
Total Debt116.64M114.28M111.49M74.08M28.55M
Net Debt53.51M38.08M26.91M4.86M(1.09M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$36.2M
Short-term Investments$65.4M
Receivables$26.3M
Inventory$8.7M
Other Current$5.6M
Total Current Assets$142.3M
PP&E (Net)$4.7M
Intangible Assets$39.0M
Other Non-current$6.8M
Total Non-current Assets$50.4M
Total Assets$192.7M

Analysis

Selected assets total $192.7M for Latest. The largest visible component is Short-term Investments at $65.4M, about 33.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
SC 13D/ASC 13D/A filingOct 6, 2026
4Statement of changes in beneficial ownershipSep 16, 2026

How much cash does PBYI have?

Puma Biotechnology, Inc. (PBYI) reported $29.64M in cash and equivalents in fiscal 2025.

How much debt does PBYI carry?

Puma Biotechnology, Inc. (PBYI) reported $28.55M of total debt, with net debt of -$1.09M.